Atlas Trials

ImmVira Pharma Co. Ltd

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ImmVira Pharma Co. Ltd

RecordFirmDate
A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor (NCT07243340)ImmVira Pharma Co. Ltd2026-04-03
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC (NCT06971614)ImmVira Pharma Co. Ltd2025-06-09
T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma (NCT05756556)ImmVira Pharma Co. Ltd2024-06-30
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma (NCT05095441)ImmVira Pharma Co. Ltd2023-03-15
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. (NCT05598268)ImmVira Pharma Co. Ltd2022-03-01
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors (NCT04780217)ImmVira Pharma Co. Ltd2021-08-10
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (NCT04370587)ImmVira Pharma Co. Ltd2020-09-17
A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors (NCT05602792)ImmVira Pharma Co. Ltd2020-04-21

Track ImmVira Pharma Co. Ltd automatically

Every clearance here is in the API, with alerts when new ones post.